Brooklyn, NY, United States of America

Khaled J Barakat


Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 1998-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Melanocortin Receptor Agonists by Khaled J Barakat

Introduction

Khaled J Barakat is a notable inventor based in Brooklyn, NY, recognized for his contributions to the field of pharmaceutical innovations. With a total of five patents to his name, Barakat has been instrumental in developing novel compounds designed to target the human melanocortin receptors, particularly the melanocortin-4 receptor (MC-4R).

Latest Patents

Barakat's latest patents focus on bridged piperidine derivatives as melanocortin receptor agonists. These innovative compounds show promise in the treatment, control, or prevention of various diseases and disorders that respond to MC-4R activation. This includes conditions such as obesity, diabetes, and sexual dysfunction, which encompasses both erectile dysfunction and female sexual dysfunction.

Another patent by Barakat centers on substituted piperidines that act as melanocortin receptor agonists. Similar to his previous work, these 4-substituted piperidine compounds selectively target the human MC-4R, indicating their potential utility in addressing health issues associated with the activation of this receptor.

Career Highlights

Khaled J Barakat is currently affiliated with Merck & Company, Inc., a leading global healthcare company. His work at Merck showcases his commitment to advancing medical science through innovative research and development in pharmacology.

Collaborations

Throughout his career, Barakat has collaborated with esteemed colleagues such as Ravi P Nargund and Iyassu K Sebhat. These collaborations have likely enriched his research endeavors and contributed to the successful development of his patented innovations.

Conclusion

Khaled J Barakat's innovative work in developing melanocortin receptor agonists establishes him as a significant figure in the pharmaceutical industry. His contributions hold the promise of offering new therapeutic solutions for obesity, diabetes, and sexual dysfunction, thereby enhancing the quality of life for many individuals. As he continues his work at Merck & Company, Barakat remains a pivotal player in the evolution of medical treatments targeting critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…